Session Details
[FP19]Free Paper 19
Fri. Jun 19, 2026 8:30 AM - 9:30 AM JST
Fri. Jun 19, 2026 11:30 PM - 12:30 AM UTC
Fri. Jun 19, 2026 11:30 PM - 12:30 AM UTC
ポスター会場(パシフィコ横浜ノース 1F G1~G4)FP19,FP22,FP25,FP28,FP31
Chairperson:Ryoko Yamazawa(Oizumi Hospital)
[2-FP19-1]なんで昔から世界中で100人に1人が統合失調症になるの?進化精神医学の視点から解き明かす統合失調症の機能
Tomofumi Arata (Hillside Clinic)
[2-FP19-2]LAIの理解と痛み軽減への期待は導入意欲を高めるか:5分動画を用いた三時点比較研究
Kohei Fujita1, Ryosuke Aratake4, Shingo Kanata1, Yuko Sugimoto1, Wakana Furukawa2, Mori Ysuhiro2, Makoto Nishihara3, Jun Miyata1 (1.Neuropsychiatric Department, Aichi Medical University, 2.Kasadera-seichiryo Hospital, 3.Multidisciplinary Pain Center, Aichi Medical University, 4.Matsukage Hospital)
[2-FP19-3]非内服抗精神病薬治療によって寛解に至ったドパミン過感受性を伴う治療抵抗性統合失調症の一例
Masaomi Iyo1,2, Tasuku Hashimoto2, Hideki Komatsu2, Michiko Nakazato2 (1.IUHW Graduate School, 2.IUHW Narita Hospital, Departmento of Psychiatry)
[2-FP19-4]メタ認知的対処の自己評価尺度(MCSS)の臨床的妥当性の検討
Yukako Yano1,2, Keiko Kubo1, Hiroki Tanoue2, Takuma Ishigaki3 (1.Graduate School of Nursing Science, University of Miyazaki, 2.School of Nursing, Faculty of Medicine, University of Miyazaki, 3.Graduate School of Arts and Sciences, The University of Tokyo)
[2-FP19-5]レセプトデータを用いた初回エピソード統合失調症の患者特性および過去の精神疾患有無別のアウトカムの評価
Yoshiteru Takekita1, Takaharu Azekawa2, Kenji Baba3, Tadashi Nosaka3, Takumi Tajima4, Yujiro Funakoshi4, Yoshimitsu Takamatsu4, Masaki Kato1 (1.Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 2.Shioiri Mental Clinic, 3.Medical Affairs, Sumitomo Pharma Co., Ltd., 4.JMDC, Inc)
[2-FP19-6]自我障害に注目した治療抵抗性統合失調症の層別化
Akane Yoshikawa1, Chihiro Kakiuchi1, Hitoshi Maeshima1, Rie Inami1, Seiya Shikiba1, Yui Okubo2, Hitoki Hirose1, Hajime Baba1, Tadafumi Kato1 (1.Department of Psychiatry and Behavioral Science Juntendo University Graduate School of Medicine, 2.Department of Pharmacorogy Juntendo University of Medicine, Juntendo Koshigaya Hospital)
